RadNet, Inc. 10-Q Summary: Period Ended September 30, 2010
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2010. RadNet, Inc. operates as the leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, with 192 facilities across seven states (primarily California, Maryland, Florida, Kansas, Delaware, New Jersey, and New York). The company provides MRI, CT, PET, nuclear medicine, mammography, and other diagnostic imaging services. Operations are reported as a single segment.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2010 | Nine Months Ended Sep 30, 2010 |
|---|---|---|
| Net Revenue | $140.1 million | $403.2 million |
| Income from Operations | $11.4 million | $25.7 million |
| Net Loss (GAAP) | $(0.3) million | $(16.1) million |
| Net Loss Per Share (Basic/Diluted) | $(0.01) | $(0.44) |
| Adjusted EBITDA | $28.0 million | $76.0 million |
| Cash and Cash Equivalents | $24.5 million | (Balance Sheet) |
| Working Capital | $29.5 million | (Balance Sheet) |
| Total Debt (Notes Payable + Leases) | ~$507 million | (Balance Sheet) |
Note: Total debt includes $488.7 million in notes payable and $16.8 million in capital lease obligations.
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased 5.0% ($6.7 million) for the quarter and 2.7% ($10.7 million) for the nine months compared to the prior year periods. This growth was driven by acquisitions ($10.4 million in Q3; $31.6 million YTD), offset by a decline in patient scheduling at existing centers.
- Operating Expenses: Total operating expenses increased 3.6% for both the quarter and nine months. Salaries and professional reading fees rose due to new acquisitions, while medical supplies expenses decreased due to vendor changes and rebates.
- Debt Refinancing Impact: The nine-month net loss was significantly impacted by a $9.9 million loss on extinguishment of debt recorded in Q2 following a major refinancing on April 6, 2010. This replaced the prior GE Credit Facility with a new $585 million capital structure.
- Interest Expense: Interest expense decreased 8.0% year-over-year for the nine months ($35.5 million vs. $38.5 million), primarily due to the removal of amortization related to prior interest rate swap modifications, partially offset by interest on new borrowings.
Guidance, Outlook, and Risks
Management Commentary: Management emphasizes a strategy of maximizing performance at existing facilities, profitable contracting, and expanding MRI, CT, and PET applications. The company believes its payor diversity mitigates exposure to unfavorable reimbursement trends.
Recent Developments: On October 1, 2010 (subsequent to the period end), RadNet acquired Image Medical Corporation (parent of eRAD, Inc.) for $10.75 million to enhance its radiology information technology capabilities.
Risks and Contingencies:
- Healthcare Reform: The Patient Protection and Affordable Care Act (PPACA) and subsequent reconciliation acts are expected to decrease revenue for Medicare beneficiaries by increasing the equipment utilization factor for advanced imaging, effectively lowering reimbursement rates starting in 2011.
- Liquidity and Debt Covenants: The company operates in a capital-intensive industry with significant fixed costs. The new credit agreement includes restrictive covenants, including minimum interest coverage ratios and maximum leverage ratios. Failure to comply could result in immediate acceleration of debt.
- Interest Rate Swaps: Following the April 2010 refinancing, existing interest rate swaps no longer qualify as cash flow hedges. Changes in their fair value are now recognized in earnings, creating volatility in "Other expenses."
Investor Verification Checklist
- Debt Covenant Compliance: Verify current compliance with the minimum interest coverage and maximum leverage ratios under the new $585 million credit facility.
- Reimbursement Trends: Monitor the impact of the PPACA utilization factor changes on Medicare reimbursement rates for advanced imaging (MRI, CT, PET) in 2011.
- Acquisition Integration: Assess the revenue contribution and integration costs of recent acquisitions (e.g., Truxtun Medical Group, Union Imaging) versus the decline in patient scheduling at legacy centers.
- Interest Rate Exposure: Review the impact of the de-designation of interest rate swaps on future earnings volatility.
- Cash Flow Sufficiency: Confirm that operating cash flows ($50.2 million YTD) remain sufficient to service the $507 million debt load and fund capital expenditures ($67.6 million YTD investing outflow).